Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta

  • Home
  • India
  • Delhi
  • Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta

Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta To know more..like this page...and learn more about the treatment.

As per american guidelines, medical treatment alone is very much possible for heart vessel blockage or blockage in heart without need for angioplasty/bypass surgery. Many clinical studies have proved that angioplasty/bypass surgery gives no benefit compared to medical treatment in many patients of blockage in heart & its results are almost equal to that of medical treatment or sometimes even inferior to that of medical treatment. This is the only reason american heart association & american college of cardiology have made some guidelines in favour of medical treatment which every doctor should follow.Due to these guidelines only recently in america angioplasty/bypass surgery have been reduced to the tune of 40% which is a remarkable figure.

06/03/2026

AHA updated scientific statement on measurement of BP

Good technique with validated, automated blood pressure machine use is key to accuracy, according to an updated scientific statement on BP measurement from the American Heart Association (AHA).

To ensure accurate measurement of BP, the AHA has issued recommendations on training in auscultatory BP measurement, assessment of knowledge of the doctor, skills of the technician or provider, among others.

Among the key recommendations are:

The observer must be able to see the manometer dial at eye level without straining and read the sphygmomanometer no further than 3 ft away.
The observer must be able to hear the Korotkoff sounds and be able to conduct the cuff deflation, listen to Korotkoff sounds and read the sphygmomanometer simultaneously.
Only well maintained validated devices must be used.
Observers should also know how to interpret and how and when to communicate BP readings to healthcare providers and patients.
Retraining of healthcare professionals should be considered every 6 months to 1 year.
The appropriate cuff size should be selected.
o Arm circumference should be measured at the midpoint of the acromion and olecranon.

o BP cuff bladder length should be 75-100% of the measured arm circumference.

o BP cuff bladder width should be at 37-50% of the patient’s arm circumference.

o Avoid rolling up the shirtsleeves as a tourniquet effect may result.

The observer must understand variability of BP by time of day, exercise, and timing of antihypertensive medication consumption
o Systolic BP is 3–10 mmHg higher in the supine than the seated position.

o Diastolic BP is ≈1–5 mmHg higher when measured supine vs seated

o Crossing legs during BP measurement may raise SBP by 5–8 mmHg and DBP by 3–5 mmHg.

o If a patient’s back is not supported (e.g., the patient is seated on an examination table), SBP and DBP may be increased by 5-15 and 6 mmHg, respectively

AHA has also described following six steps for proper seated office BP measurement:

Properly prepare the patient
Use proper technique for BP measurements
Take the proper measurements needed for diagnosis and treatment of elevated BP/hypertension
Properly document accurate BP readings
Average the readings
Provide BP readings to patient

26/02/2026

!! No Late Benefit From Early Angioplasty in Stable Heart Disease Even In Patients Having 90-100% Blockage - Courage Study Extended Follow up - NEJM !!

No need of angioplasty if your symptoms like chest pain or breathlessness are stable & not progressing over time. Medical treatment alone is possible & recommended as per American guidelines (AHA/AHC) even in patients having 90-100% blockage of two or three vessels

24/02/2026

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026.1 The...

23/02/2026

!! Silent Bradyarrhythmia Needs No Treatment & No Pacemaker Is Needed !!
- Study Published in JAMA Cardiology 15th Feb 2023

Bradycardia is a lot more common than generally believed, but is often asymptomatic and not clinically relevant, and may lead to needless pacemaker therapy, suggests a post-hoc analysis of a major study.

The arrhythmia's presence overall in the randomized LOOP trial predicted an excess risk of syncope and death, and it didn't matter how it was detected. Bradyarrhythmia revealed incidentally at long-term cardiac rhythm monitoring was no more predictive than when it was picked up in a usual-care setting.
Still, people in the trial with implantable loop recorders (ILR) had six times the chance of being diagnosed with bradyarrhythmias than those in the usual-care control group. LOOP entered older persons in the community without known arrhythmias but with risk factors like diabetes or hypertension.
About 80% of such arrhythmias at ILR monitoring were asymptomatic, compared to less than one fourth in the usual-care group. Yet pacemaker implantation for bradyarrhythmia was 53% more likely in the ILR group, according to a report published February 15 in JAMA Cardiology.
Most participants with asymptomatic bradycardia did not receive treatment for it, yet the study — despite the mostly conservative management — still showed "overtreatment with pacemakers" in the ILR group, observed lead author Søren Zöga Diederichsen, MD, PhD, Copenhagen University Hospital–Rigshospitalet, Copenhagen, Denmark.

Bradyarrhythmia overall predicted later syncope and all-cause and cardiovascular (CV) death, but did so regardless of whether the patient was ILR-monitored or received a pacemaker.
"We didn't see any signal, not even a small signal, toward a health benefit from monitoring and detecting bradycardias, or from acting on them conservatively or implanting pacemakers," he noted.
The study "emphasizes that you should have symptoms" to justify pacemaker therapy for bradyarrhythmias, regardless of how they were detected, Diederichsen said.
"Clearly ILRs may identify patients with bradyarrhythmias deserving of treatment" when they are associated with symptoms, an accompanying editorial agrees. In the current analysis, however, "a large proportion of bradycardic events were completely asymptomatic." Yet bradycardia predicted syncope and CV death in both the ILR and usual care groups, it notes.
"This does raise the question as to whether bradyarrhythmia may be a risk marker for underlying nonarrhythmic conditions to which preventive strategies and treatment should be directed," write editorialists Mark H. Schoenfeld, MD, Yale University, New Haven, Connecticut, and Kristen K. Patton, MD, University of Washington, Seattle.
"In an aging population with ever-increasing comorbidities, it may become increasingly important to rule out bradycardia as a manifestation of a more sinister underlying disease," they note, and to identify "patients who may be particularly vulnerable to adverse outcomes of progressive distal conduction disease."
The previously published LOOP trial, conducted at four sites in Denmark, compared ILR screening for AF to usual care in 6004 patients at least 70 years or older, most with hypertension. The main results showed little benefit from screening for AF in prevention of incident stroke or systemic embolism over about 5 years.
The current LOOP analysis, post-hoc with all the associated limitations, followed incident bradyarrhythmia in the ILR and usual-care groups; any treatment of the arrhythmia was at physician discretion. The total cohort averaged 75 years in age and 47.3% were women.

The rate of incident bradyarrhythmia was 8.1% overall; it was 20.8% for those with ILR monitoring and 3.8% in the usual care group, for a hazard ratio (HR) of 6.21 (95% CI, 5.15 - 7.48, P < .001).
The arrhythmia was asymptomatic in 23.8% of usual-care patients and 79.8% of those with an ILR.
Bradyarrhythmia was significantly more likely among older patients, male patients, and those with a history of syncope, the group reported.

Pacemakers were implanted for bradyarrhythmia in 2.9% of usual-care patients and 4.5% of those with ILR monitoring for an HR of 1.53 (95% CI, 1.14 - 2.06, P < .001).
Among usual-care patients, bradyarrhythmia (vs no bradyarrhythmia) was associated with 5.2 times the risk for incident syncope (P < .001). That risk for syncope went up 2.6 times (P = .01) in the ILR group.
The corresponding risks for CV death among controls and among ILR patients increased 4.8 times (P < .001) and by 3.1 (P < .001), respectively. The risks for death from any cause tripled (P < .001) and rose 2.5 times (P < .001) among bradycardic controls and ILR patients, respectively.

Bradyarrhythmia was not significantly related to sudden cardiac death in either group, the report notes.
Given the increasing use of heart rhythm monitoring "inside and outside the clinical setting," it states, "bradyarrhythmias are likely to be detected more often, sometimes as an incidental finding. Knowledge about the underlying prevalence and prognostic significance could help guide decisions."
The study "teaches us a little bit" about the true prevalence of bradyarrhythmias in the general population, including asymptomatic cases that appear to be subclinical or "physiological," Diederichsen said in an interview.

It also suggests that such bradycardia will be increasingly observed as use of ILR for arrhythmia screening expands in practice, he predicted. It may also be picked up more often by wearables and other rhythm-monitoring technology used by the public.
In the latter case especially, Diederichsen said, the current analysis could potentially help alleviate any concerns that bradyarrhythmia without symptoms is something that has to be specifically treated.

15/02/2026

Seven Behaviors Can reduce the risk of Heart Deaths

Seven heart-healthy behaviors can reduce the risk of death from cardiovascular disease. In a prospective study, by Enrique Artero, PhD, of the University of South Carolina, and colleagues, published in the journal Mayo Clinic Proceedings, those who met 3-4 of the American Heart Association’s ‘Simple Seven’ heart-health criteria had a 55% lower risk of cardiovascular mortality than those who met no more than two of those practices over 11 years.

Four core behaviors

No smoking
Normal body mass index
Engaging in physical activity
Eating healthfully
Three parameters

Cholesterol lower than 200 mg/dL
Blood pressure lower than 120/80 mmHg
Not having diabetes

01/02/2026

Three benefits of outdoor winter exercise
-you burn more calories
-your mood improves
-your overall health improves

You burn more calories: Research shows that exercising regularly in cold temperatures can increase the production of calorie-burning brown fat by 45% and can increase your overall metabolism significantly. This may be helpful in preventing the winter weight that often accrues due to lower levels of daily activity, reduced intake of fresh fruit and salad, and increased intake of comfort foods such as mashed potatoes and meatloaf.
Your mood improves: Exercise in general improves mood and can help reduce anxiety, stress and depression, but exercising outdoors may have added benefits, according to some studies. A study found that climbing outdoors for several hours, compared with indoor walking on a treadmill, improved feelings of pleasure and reduced feelings of fatigue.
Both exercise groups were calmer, less anxious and happier than a sedentary group, so if you really hate the cold, indoor exercise is definitely better than none.
Your overall health improves: Exercise is great for your health, but exercising outdoors may be even better. According to a large study from the National Health and Nutrition Examination Survey, outdoor exercise may decrease the risk of dying from cardiovascular disease by up to 27% over being sedentary, and it was strongly associated with higher levels of vitamin D.

25/01/2026

Smoking Even One Cigarette a Day Raises Cardiovascular Risk

LONDON — For people who think that smoking only one or two ci******es a day carries little cardiovascular risk, a powerful new study maintains the only way to reduce risk is to quit, full stop.[1]
The investigators anticipated that smoking one cigarette a day would be associated with about 5% of the excess relative risk of smoking 20 ci******es a day, but they found it actually accounts for 46% of excess CHD risk in men and 31% of the risk in women.

For the less commonly reported smoking-related outcome of stroke, the excess risk associated with just one cigarette per day was 41% for men and 34% for women.
The meta-analysis of data from 141 prospective cohort studies was published online today in the British Medical Journal.
"There's been a big shift from people smoking 20 to 25 ci******es a day to only smoking a few ci******es a day with the assumption that's good enough for them. Their view is that smoking only a couple a day can't be harmful and that's probably not far off the truth for risk for cancer. For many smokers that's probably the first thing that comes to mind, but cardiovascular risk is the big one," lead author, Dr Allan Hackshaw (University College London, UK), told theheart.org | Medscape Cardiology.

He continued, "So the main public health impact of this is that smokers have done well in reducing and there are various methods to help them quit and cut down, but the aim is to keep on searching for those methods, find one that suits them, and to cut down and then quit completely."
Dr Vincent Bufalino (Advocate Health Care, Chicago, IL), who was not involved in the study, said the findings are not what many physicians would have predicted but that the investigators have built a "very convincing case" in a pretty impressive set of data.
"I think this is actually stunning in that it's an all-or-nothing phenomenon now," he said. "It's going to change our thinking. Of course we wanted people to quit. It's not like we were trying to encourage people to reduce; we would take that only as the third option if everything else failed. But now we have some hard data that says even a cigarette a day is harmful—and not just a little harmful, but increases your risk 50% to 75% of the time. Wow! And it's even more impressive in women."

The excess CVD risk associated with low smoking has been reported since the 1990s and is likely known by expert cardiologists, especially those familiar with to***co research, but "in terms of a lot of the everyday practicing cardiologists, I have the feeling that they don't," Hackshaw said.
"It could be possibly that when those occasional reports have come out in journals and in the media, they're only based on one study—people say it's only one study, it might be a fluke and that's why it hasn't sunk in properly," he added.
Women, Be Wary

The 141 cohort studies in the meta-analysis were published between 1946 and May 2015 and followed 5.6 million patients for CHD and 7.3 million for stroke. Each study had at least 50 hard events, with 110,000 new cases of CHD and 135,000 cases of stroke reported.
Compared with never smoking, smoking one cigarette a day was associated with a 48% increase in CHD risk for men across all studies (relative risk [RR], 1.48; 95% CI, 1.30–1.69) and a 74% increase in studies controlling for multiple confounders in addition to age and s*x (RR, 1.74; 95% CI, 1.50–2.03). For women, smoking one cigarette a day was associated with a 57% (RR, 1.57; 95% CI, 1.29–1.91) to 119% (RR, 2.19; 95% CI, 1.84–2.61) increase in CHD risk.
Further, smoking 20 ci******es per day was estimated to increase CHD risk in men by 104% (all studies: RR, 2.04; 95% CI, 1.86–2.24) to 127% (adjusted studies: RR, 2.27; 95% CI, 1.90–2.72) and in women by a staggering 184% (all studies: RR, 2.84; 95% CI, 2.21–3.64) to 295% (adjusted studies: RR, 3.95; 95% CI, 3.34–4.67).

"There's a bit of uncertainty why the effect is higher in women," said Hackshaw. There may be biological causes, differences in inhalation, or that women have lagged behind in terms of quit rates. "But we are seeing the effects on a population of what the risks of heart disease and stroke are."
"The unfortunate thing for cardiovascular disease is that the adverse effects seem to come through quite quickly after only 2 or 3 years of smoking and the impact is quite big," he added. "The good thing is that if you quit smoking, a lot of your risk goes away quite quickly as opposed to cancer, where it takes several years to mainly go away."
The risk for stroke was slightly lower than that for CHD, but again the data suggest a slightly larger effect among women than men, particularly among heavy smokers. Across all studies, the relative risks for stroke were 1.25 (95% CI, 1.13–1.38) in men who smoked one cigarette per day and 1.31 (95% CI, 1.13–1.52) in women; the corresponding risk estimates for men and women smoking a pack a day were 1.64 (95% CI, 1.48–1.82) and 2.16 (95% CI, 1.69–2.75), respectively.

While the stroke risk may be lower, Dr Nancy Rigotti (director of Massachusetts General Hospital's To***co Research and Treatment Center, Boston) said in an interview, "It's still quite high. A 30% increased risk is huge. So I think it just reinforces the message that even one cigarette puts you at risk of heart attack and strokes."
e-Cigarettes for Harm Reduction?

In an accompanying editorial,[2] Dr Kenneth C Johnson (University of Ottawa, Ontario) writes, "Any assumption that smoking less protects against heart disease or stroke has been dispelled this week in the BMJ."
He notes that light smoking, occasional smoking, and smoking fewer ci******es all carry substantial risk for CVD and that "only complete cessation is protective and should be emphasised by all prevention measures and policies."

Johnson argues that although e-ci******es deliver reduced levels of carcinogens, regulatory approval should be withheld for the devices and that "e-ci******es and heat-not-burn products should not be promoted for 'harm reduction' on the grounds that they lead people to smoke fewer ci******es, because modest reductions in cigarette consumption are unlikely to have meaningful health benefits and dual use of ci******es and e-ci******es may expose smokers to increased total risk."
"I actually think I would disagree with that," Rigotti countered. "e-Cigarettes are ni****ne-delivery devices. They don't burn to***co and so they don't expose users to the products of combustion, and most of what we understand about what causes cardiovascular disease in smokers is really the products of combustion, not the ni****ne."
She noted that a National Academy of Science (NAS) e-cigarette report released earlier this week that she coauthored is consistent with that view. "We would expect that someone would have a very different risk if they were va**ng the equivalent of a cigarette a day compared to smoking a cigarette per day, so that switching from one cigarette per day to an equivalent amount of va**ng would almost certainly reduce risk."

Hackshaw agreed: "It's highly, highly unlikely or unfeasible that e-ci******es are going to have the same impact on cardiovascular risk factors or the cardiovascular system as smoking one or two ci******es a day, but there are some studies in place that are going to be looking at the long-term effects of that."
He continued, "There are some people who have been concerned about what the effects of e-ci******es are on the cardiovascular system. And that's all good and well, but in the current state of play if you've got some current smokers who really cannot quit, do they carry on smoking 25 or 30 a day or do you get them to cut down? And one of the best ways to help them cut down is e-ci******es."
"Perhaps the most important point to be made there is that if a smoker just substitutes a few ci******es with e-ci******es but continues to smoke regular ci******es as well, they're probably not reducing their risk and that is what this article says," Rigotti said. "Because if they're smoking even one cigarette a day, it doesn't matter how much they're va**ng because they're still giving themselves a risk."

However, Johnson also points out that e-ci******es may attract a whole new generation of young smokers. There is evidence of this in the NAS report, but modeling of overall population risks suggests the number of lives saved by having e-ci******es available to help people quit is greater than the small number of teens who may be induced to smoke who otherwise would not have, Rigotti said.
"Almost certainly there is harm reduction, and furthermore, someone who starts va**ng does not necessarily stay va**ng forever. Many of them could and do eventually wean off the e-ci******es," she said.

14/01/2026

!! Angioplasty is not better than medical treatment alone in stable heart blockage patients !!

The results of COURAGE TRIAL and consequent american guidelines revisions have not, to date, been fully incorporated into clinical practice in a large cross-section of hospitals in the United States. Overall, fewer than half of all patients received appropriate treatment with the combination of common cardiac drugs used in the COURAGE trial, before their stenting procedure, and almost one-third didn't receive these drugs afterward.To find out, the researchers studied 1,013 U.S. hospitals in what they believe to be the largest PCI registry in the United States. They analyzed clinical data on 467,211 patients. The researchers report in the May 11 issue of JAMA, the Journal of the American Medical Association

08/01/2026

!! In chronic stable angina, medical treatment is the first line treatment even in three vessel disease if ischemia is

08/01/2026

Angiogioplasty 24 hours after heart attack gives no benefit in stable patients & not recommended as per American guidelines (AHA/ACC) but it remains commonplace despite little evidence to support its use.The results of OAT (occluded artery trial) and consequent guideline revisions have not, to date, been fully incorporated into clinical practice in a large cross-section of hospitals in the United States. Percutaneous coronary intervention of total occlusions identified greater than 24 hours after MI remains commonplace despite little evidence to support its use in stable patients and new clinical practice guidelines recommending against it." A report published in one of the Less is More series of the Archives of Internal Medicine, one of the JAMA/Archives

06/01/2026

!! Weight loss can make diabetes remission possible !!

Recent study led by the University of Cambridge has suggested that people who achieve weight loss of 10% or more in the first five years after the diagnosis with type 2 diabetes have the highest chances of seeing their diabetes go in remission. The results of the study suggest that it is possible to recover from the disease without intensive lifestyle interventions or extreme calorie restrictions. Researchers found that 257 study participants (30%) were in remission at five-year follow-up. People who achieved weight loss of 10% or more within the first five years after diagnosis were more than twice as likely to go into remission compared to people who maintained the same weight.

05/01/2026

!! No Late Benefit From Early Angioplasty in Stable Heart Disease Even In Patients Having 90-100% Blockage- Courage Study !!

No need of angioplasty if your symptoms like chest pain or breathlessness are stable & not progressing over time. Medical treatment alone is possible & recommended as per American guidelines (AHA/AHC) even in patients having 90-100% blockage of two or three vessels

Address

485, Kohat Enclave, Pitampura
Delhi
110034

Alerts

Be the first to know and let us send you an email when Heart Treatment Without Angioplasty / Bypass surgery - dr dk gupta posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category